FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3085619150> ?p ?o ?g. }

• W3085619150 endingPage "2720" @default.
• W3085619150 startingPage "2713" @default.
• W3085619150 abstract "OBJECTIVE To evaluate the incidence and risk factors for diabetic ketoacidosis (DKA) and related adverse events (AEs) in adults with type 1 diabetes treated with sotagliflozin adjunctive to insulin. RESEARCH DESIGN AND METHODS Data from two identically designed, 52-week, randomized studies were pooled and analyzed for DKA, changes in β-hydroxybutyrate (BHB), and percentage of patients with BHB &gt;0.6 and &gt;1.5 mmol/L. The patients were administered placebo, sotagliflozin 200 mg, or sotagliflozin 400 mg once daily. RESULTS A total of 191 ketosis-related AEs were reported, and 98 underwent adjudication. Of these, 37 events (36 patients) were adjudicated as DKA, with an exposure-adjusted incidence rate of 0.2, 3.1, and 4.2 events per 100 patient-years for placebo, sotagliflozin 200 mg, and sotagliflozin 400 mg, respectively. No patient died of a DKA event. From a baseline BHB of ∼0.13 mmol/L, sotagliflozin treatment led to a small median increase over 52 weeks (≤0.05 mmol/L at all time points). Of sotagliflozin-treated patients, approximately 47% and 7% had ≥1 BHB measurement &gt;0.6 mmol/L and &gt;1.5 mmol/L, respectively (vs. 20% and 2%, respectively, of placebo-treated patients). Subsequent to the implementation of a risk mitigation plan, annualized DKA incidence was lower versus preimplementation in both the sotagliflozin 200 and 400 mg groups. CONCLUSIONS In patients with type 1 diabetes, confirmed DKA incidence increased when sotagliflozin was added to insulin compared with insulin alone. A lower incidence of DKA was observed following the implementation of an enhanced risk mitigation plan, suggesting that this risk can be managed with patient education." @default.
• W3085619150 created "2020-09-21" @default.
• W3085619150 creator A5013876679 @default.
• W3085619150 creator A5017305166 @default.
• W3085619150 creator A5020174004 @default.
• W3085619150 creator A5044067556 @default.
• W3085619150 creator A5050005771 @default.
• W3085619150 creator A5071945904 @default.
• W3085619150 creator A5075068326 @default.
• W3085619150 creator A5078506759 @default.
• W3085619150 creator A5081758034 @default.
• W3085619150 creator A5081984589 @default.
• W3085619150 creator A5084593004 @default.
• W3085619150 date "2020-09-14" @default.
• W3085619150 modified "2023-09-25" @default.
• W3085619150 title "Diabetic Ketoacidosis and Related Events With Sotagliflozin Added to Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of the inTandem 1 and 2 Studies" @default.
• W3085619150 cites W1955935325 @default.
• W3085619150 cites W1957004156 @default.
• W3085619150 cites W2019439229 @default.
• W3085619150 cites W2046299854 @default.
• W3085619150 cites W2066245509 @default.
• W3085619150 cites W2098570086 @default.
• W3085619150 cites W2108371350 @default.
• W3085619150 cites W2114445980 @default.
• W3085619150 cites W2116974726 @default.
• W3085619150 cites W2341757727 @default.
• W3085619150 cites W2412800896 @default.
• W3085619150 cites W2559579283 @default.
• W3085619150 cites W2579350152 @default.
• W3085619150 cites W2739992854 @default.
• W3085619150 cites W2755899227 @default.
• W3085619150 cites W2756104796 @default.
• W3085619150 cites W2765549757 @default.
• W3085619150 cites W2803462035 @default.
• W3085619150 cites W2809153459 @default.
• W3085619150 cites W2809590939 @default.
• W3085619150 cites W2884380775 @default.
• W3085619150 cites W2886675799 @default.
• W3085619150 cites W2888702569 @default.
• W3085619150 cites W2894624538 @default.
• W3085619150 cites W2913123058 @default.
• W3085619150 cites W2918957897 @default.
• W3085619150 cites W2950136952 @default.
• W3085619150 cites W2952862095 @default.
• W3085619150 cites W2955843024 @default.
• W3085619150 cites W2963497681 @default.
• W3085619150 cites W2971963762 @default.
• W3085619150 cites W2982570207 @default.
• W3085619150 cites W4211168619 @default.
• W3085619150 doi "https://doi.org/10.2337/dc20-0924" @default.
• W3085619150 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7576419" @default.
• W3085619150 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32928957" @default.
• W3085619150 hasPublicationYear "2020" @default.
• W3085619150 type Work @default.
• W3085619150 sameAs 3085619150 @default.
• W3085619150 citedByCount "12" @default.
• W3085619150 countsByYear W30856191502020 @default.
• W3085619150 countsByYear W30856191502021 @default.
• W3085619150 countsByYear W30856191502022 @default.
• W3085619150 countsByYear W30856191502023 @default.
• W3085619150 crossrefType "journal-article" @default.
• W3085619150 hasAuthorship W3085619150A5013876679 @default.
• W3085619150 hasAuthorship W3085619150A5017305166 @default.
• W3085619150 hasAuthorship W3085619150A5020174004 @default.
• W3085619150 hasAuthorship W3085619150A5044067556 @default.
• W3085619150 hasAuthorship W3085619150A5050005771 @default.
• W3085619150 hasAuthorship W3085619150A5071945904 @default.
• W3085619150 hasAuthorship W3085619150A5075068326 @default.
• W3085619150 hasAuthorship W3085619150A5078506759 @default.
• W3085619150 hasAuthorship W3085619150A5081758034 @default.
• W3085619150 hasAuthorship W3085619150A5081984589 @default.
• W3085619150 hasAuthorship W3085619150A5084593004 @default.
• W3085619150 hasBestOaLocation W30856191501 @default.
• W3085619150 hasConcept C120665830 @default.
• W3085619150 hasConcept C121332964 @default.
• W3085619150 hasConcept C126322002 @default.
• W3085619150 hasConcept C134018914 @default.
• W3085619150 hasConcept C142724271 @default.
• W3085619150 hasConcept C204787440 @default.
• W3085619150 hasConcept C27081682 @default.
• W3085619150 hasConcept C2775849729 @default.
• W3085619150 hasConcept C2776731943 @default.
• W3085619150 hasConcept C2779306644 @default.
• W3085619150 hasConcept C2781232474 @default.
• W3085619150 hasConcept C2781283889 @default.
• W3085619150 hasConcept C555293320 @default.
• W3085619150 hasConcept C61511704 @default.
• W3085619150 hasConcept C71924100 @default.
• W3085619150 hasConcept C90924648 @default.
• W3085619150 hasConceptScore W3085619150C120665830 @default.
• W3085619150 hasConceptScore W3085619150C121332964 @default.
• W3085619150 hasConceptScore W3085619150C126322002 @default.
• W3085619150 hasConceptScore W3085619150C134018914 @default.
• W3085619150 hasConceptScore W3085619150C142724271 @default.
• W3085619150 hasConceptScore W3085619150C204787440 @default.
• W3085619150 hasConceptScore W3085619150C27081682 @default.
• W3085619150 hasConceptScore W3085619150C2775849729 @default.
• W3085619150 hasConceptScore W3085619150C2776731943 @default.

• next